Avastin plus chemotherapy for metastatic colorectal cancer increases over time

Results of a recent study demonstrate that the proportion of patients with metastatic colorectal cancer treated with the chemotherapy regimen FOLFOXIRI and Avastin (bevacizumab) increases over time, especially in patients younger than 50 years. . Results of this study were presented at the 2024 ASCO Gastrointestinal Cancer Symposium. FOLFOXIRI is a chemotherapy regimen consisting of […]

Fruquintinib combination therapy improves quality-adjusted survival in metastatic colorectal cancer

3D illustration of the colon – Stock.adobe.com The combination of fruquintinib (Fruzakura) and optimal supportive care led to Results from an in-phase post-hoc analysis show that quality-adjusted time to absence of symptoms of disease or toxicity increased when compared with placebo and optimal supportive care in previously treated patients with metastatic colorectal cancer (CRC). The […]

New PET tracer accurately detects common cancer mutations and enables targeted treatment

New PET imaging tracers have been proven to safely and effectively detect common cancer gene mutations, which are important molecular markers for tumor-targeted therapies. Identifying this mutation early allows doctors to tailor treatment plans to patients to achieve the best results. The study was published in the December issue of the journal. nuclear medicine journal. […]

New study shows better biomarkers for MSI mCRC

This transcript has been edited for clarity. I’m David Kerr, Professor of Cancer Medicine at the University of Oxford.Today I would like to talk about the following A really great paper published earlier this year Oncology annual report By an excellent French group. As you know, we have always had a strong interest in precision […]

First-in-class targeted therapy has potential for colon cancer

Germany’s Merck KGaA (MRK:DE) announced a licensing agreement with New York-based small molecule developer Inspirna. The agreement is for ompenacrid, a first-in-class SLC6A8 blocker, and will also include other similar follow-on compounds. Omphenacrid is currently being evaluated in a Phase II trial for second-line treatment of certain people with advanced or metastatic colorectal cancer (mCRC). […]

Research identifies promising treatment for advanced colorectal cancer

An international phase 3 clinical trial showed that patients with metastatic colorectal cancer who carry a rare genetic tumor mutation called KRAS G12C received a combination of the KRAS inhibitor sotorasib and the monoclonal antibody panitumumab compared to standard treatment. It was found that an excellent progression-free survival rate was achieved. City of Hope is […]

The man thought the pain was caused by a new exercise regimen. he had cancer.

When JJ Singleton noticed a throbbing pain in her abdomen in May 2015, she chalked it up to a torn muscle. After all, the 27-year-old’s goals for this year are: “Let’s get our lives together,” that’s how he started 2015. crossfit Train with your old soccer coach. singleton, Now 36, he told Business Insider that […]

Colorectal cancer tumor growth may be promoted by cholesterol

Share on PinterestWhy statins and other cholesterol-lowering drugs can help prevent colon cancer tumor growth. Image credit: Su Bikun/VCG (Getty Images) Colon cancer screening looks for the presence of polyps, some of which can become cancerous. One type of serrated adenoma is thought to be precancerous and can recur after removal, particularly leading to invasive […]